US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist
  • 15.145
  • +0.025+0.17%
Trading May 15 11:58 ET
220.08MMarket Cap-189312P/E (TTM)

Merrimack Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.09%2.18M
-19.28%490K
5.36%531K
17.08%569K
1.56%586K
-16.90%2.17M
28.33%607K
-18.58%504K
-37.53%486K
-22.65%577K
Selling and administrative expenses
0.09%2.18M
-19.28%490K
5.36%531K
17.08%569K
1.56%586K
-16.90%2.17M
28.33%607K
-18.58%504K
-37.53%486K
-22.65%577K
-General and administrative expense
0.09%2.18M
-19.28%490K
5.36%531K
17.08%569K
1.56%586K
-16.90%2.17M
28.33%607K
-18.58%504K
-37.53%486K
-22.65%577K
Operating profit
-0.09%-2.18M
19.28%-490K
-5.36%-531K
-17.08%-569K
-1.56%-586K
16.90%-2.17M
-28.33%-607K
18.58%-504K
37.53%-486K
22.65%-577K
Net non-operating interest income expense
361.70%868K
122.03%262K
306.45%252K
2,125.00%178K
176K
840.00%188K
11,700.00%118K
62K
-57.89%8K
0
Non-operating interest income
361.70%868K
122.03%262K
306.45%252K
2,125.00%178K
--176K
840.00%188K
11,700.00%118K
--62K
-57.89%8K
--0
Other net income (expense)
-68.76%139K
0
-68.76%139K
209.03%445K
0
790.00%445K
Special income (charges)
-68.76%139K
--0
--0
--0
-68.76%139K
209.03%445K
--0
--0
--0
790.00%445K
-Gain on sale of property,plant,equipment
-68.76%139K
----
----
----
-68.76%139K
209.03%445K
----
----
----
790.00%445K
Income before tax
24.14%-1.17M
53.37%-228K
36.88%-279K
18.20%-391K
-105.30%-271K
37.15%-1.54M
-3.60%-489K
15.81%-442K
37.02%-478K
81.03%-132K
Income tax
300.00%12K
0.00%3K
Net income
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
81.03%-132K
Net income continuous Operations
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
81.03%-132K
Minority interest income
Net income attributable to the parent company
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
81.03%-132K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
81.03%-132K
Basic earnings per share
27.27%-0.08
66.67%-0.01
33.33%-0.02
25.00%-0.03
-100.00%-0.02
38.89%-0.11
0.00%-0.03
25.00%-0.03
33.33%-0.04
80.00%-0.01
Diluted earnings per share
27.27%-0.08
66.67%-0.01
33.33%-0.02
25.00%-0.03
-100.00%-0.02
38.89%-0.11
0.00%-0.03
25.00%-0.03
33.33%-0.04
80.00%-0.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.09%2.18M-19.28%490K5.36%531K17.08%569K1.56%586K-16.90%2.17M28.33%607K-18.58%504K-37.53%486K-22.65%577K
Selling and administrative expenses 0.09%2.18M-19.28%490K5.36%531K17.08%569K1.56%586K-16.90%2.17M28.33%607K-18.58%504K-37.53%486K-22.65%577K
-General and administrative expense 0.09%2.18M-19.28%490K5.36%531K17.08%569K1.56%586K-16.90%2.17M28.33%607K-18.58%504K-37.53%486K-22.65%577K
Operating profit -0.09%-2.18M19.28%-490K-5.36%-531K-17.08%-569K-1.56%-586K16.90%-2.17M-28.33%-607K18.58%-504K37.53%-486K22.65%-577K
Net non-operating interest income expense 361.70%868K122.03%262K306.45%252K2,125.00%178K176K840.00%188K11,700.00%118K62K-57.89%8K0
Non-operating interest income 361.70%868K122.03%262K306.45%252K2,125.00%178K--176K840.00%188K11,700.00%118K--62K-57.89%8K--0
Other net income (expense) -68.76%139K0-68.76%139K209.03%445K0790.00%445K
Special income (charges) -68.76%139K--0--0--0-68.76%139K209.03%445K--0--0--0790.00%445K
-Gain on sale of property,plant,equipment -68.76%139K-------------68.76%139K209.03%445K------------790.00%445K
Income before tax 24.14%-1.17M53.37%-228K36.88%-279K18.20%-391K-105.30%-271K37.15%-1.54M-3.60%-489K15.81%-442K37.02%-478K81.03%-132K
Income tax 300.00%12K0.00%3K
Net income 23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K81.03%-132K
Net income continuous Operations 23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K81.03%-132K
Minority interest income
Net income attributable to the parent company 23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K81.03%-132K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K81.03%-132K
Basic earnings per share 27.27%-0.0866.67%-0.0133.33%-0.0225.00%-0.03-100.00%-0.0238.89%-0.110.00%-0.0325.00%-0.0333.33%-0.0480.00%-0.01
Diluted earnings per share 27.27%-0.0866.67%-0.0133.33%-0.0225.00%-0.03-100.00%-0.0238.89%-0.110.00%-0.0325.00%-0.0333.33%-0.0480.00%-0.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg